Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

100%

3 of 3 completed trials have results

Key Signals

1 recruiting3 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT06337188Not ApplicableRecruiting

Adaptive and Individualized AAC Phase II

Role: lead

NCT04762043Not ApplicableCompleted

MyoVoice to Restore Natural, Hands-free Communication to Individuals With Vocal Impairments

Role: lead

NCT06245174Unknown

A Smartphone Application for Neurology and Telemedicine

Role: lead

NCT04247828Not ApplicableCompleted

Adaptive and Individualized AAC

Role: lead

NCT04717323Not ApplicableCompleted

Precision Gait Retraining for Children With Cerebral Palsy

Role: lead

All 5 trials loaded